Literature DB >> 7925353

Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine.

D R Brooks1, P Wang, M Read, W M Watkins, P F Sims, J E Hyde.   

Abstract

Dihydropteroate synthase (H2Pte synthase) is the target of the sulfur-based antimalarial drugs, which are frequently used in synergistic combination with inhibitors of dihydrofolate reductase (H2folate reductase) to combat chloroquine-resistant malaria. We have isolated the H2Pte synthase coding sequence of the most pathogenic human parasite Plasmodium falciparum. It forms part of a longer coding sequence, located on chromosome 8, that also specifies 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (CH2OH-H2pterinPP kinase) at its 5' proximal end. This domain is unusually large, with two long insertions relative to other CH2OH-H2pterinPP kinase molecules. To investigate a possible genetic basis for clinical resistance to sulfa drugs, we sequenced the complete H2Pte synthase domains from eleven isolates of P. falciparum with diverse geographical origins and levels of sulfadoxine resistance. Overall, point mutations in five positions were observed, affecting four codons. Parasite lines exhibiting high-level resistance were found to carry either a double mutation, altering both Ser436 and Ala613, or a single mutation affecting Ala581. The mutations at positions 436 and 581 have the same location relative to each of two degenerate repeated amino acid motifs that are conserved across all other known H2Pte synthase molecules. The amino acid alteration at residue 613 is identically positioned relative to a different conserved motif. The fourth amino acid residue (437) affected by mutation, though adjacent to the apparently crucial residue 436, shows no obvious correlation with resistance. Although these mutations have no exact counterparts in any other organism, that at position 581 falls within a region of three amino acids where H2Pte synthase is modified in various ways in a number of sulfonamide-resistant pathogenic bacteria. Copy-number analysis indicated that there was no amplification of the H2Pte synthase domain in resistant parasite lines of P. falciparum, compared to sensitive lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7925353     DOI: 10.1111/j.1432-1033.1994.00397.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  105 in total

Review 1.  Drug resistance in Plasmodium falciparum malaria.

Authors:  D C Warhurst
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.

Authors:  Richard J Pearce; Chris Drakeley; Daniel Chandramohan; Frank Mosha; Cally Roper
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 3.  Comparative folate metabolism in humans and malaria parasites (part II): activities as yet untargeted or specific to Plasmodium.

Authors:  Alexis Nzila; Steve A Ward; Kevin Marsh; Paul F G Sims; John E Hyde
Journal:  Trends Parasitol       Date:  2005-07

4.  Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.

Authors:  Pabitra Saha; Subhasish K Guha; Sonali Das; Shrabanee Mullick; Swagata Ganguly; Asit Biswas; Dilip K Bera; Gaurangadeb Chattopadhyay; Madhusudan Das; Pratip K Kundu; Krishnangshu Ray; Ardhendu K Maji
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

5.  Role of Plasmodium vivax Dihydropteroate Synthase Polymorphisms in Sulfa Drug Resistance.

Authors:  Wichai Pornthanakasem; Pinpunya Riangrungroj; Penchit Chitnumsub; Wanwipa Ittarat; Darin Kongkasuriyachai; Chairat Uthaipibull; Yongyuth Yuthavong; Ubolsree Leartsakulpanich
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites.

Authors:  L K Basco; R Tahar; P Ringwald
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

7.  Sulfadoxine-pyrimethamine resistance in the rodent malaria parasite Plasmodium chabaudi.

Authors:  Karen Hayton; Lisa C Ranford-Cartwright; David Walliker
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

8.  Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species.

Authors:  C Fermer; B E Kristiansen; O Sköld; G Swedberg
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

9.  Binding Isotope Effects for para-Aminobenzoic Acid with Dihydropteroate Synthase from Staphylococcus aureus and Plasmodium falciparum.

Authors:  Christopher F Stratton; Hilda A Namanja-Magliano; Scott A Cameron; Vern L Schramm
Journal:  ACS Chem Biol       Date:  2015-08-27       Impact factor: 5.100

10.  Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission.

Authors:  C B Beard; J L Carter; S P Keely; L Huang; N J Pieniazek; I N Moura; J M Roberts; A W Hightower; M S Bens; A R Freeman; S Lee; J R Stringer; J S Duchin; C del Rio; D Rimland; R P Baughman; D A Levy; V J Dietz; P Simon; T R Navin
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.